News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,527 Results
Type
Article (40632)
Company Profile (269)
Press Release (675623)
Multimedia
Podcasts (75)
Webinars (17)
Section
Business (204562)
Career Advice (2018)
Deals (35504)
Drug Delivery (104)
Drug Development (81289)
Employer Resources (173)
FDA (16350)
Job Trends (14929)
News (346101)
Policy (32695)
Tag
Academia (2559)
Accelerated approval (19)
Adcomms (24)
Allergies (122)
Alliances (49576)
ALS (144)
Alzheimer's disease (1605)
Antibody-drug conjugate (ADC) (246)
Approvals (16500)
Artificial intelligence (439)
Autoimmune disease (106)
Automation (33)
Bankruptcy (361)
Best Places to Work (11640)
BIOSECURE Act (20)
Biosimilars (165)
Biotechnology (175)
Bladder cancer (136)
Brain cancer (48)
Breast cancer (524)
Cancer (4134)
Cardiovascular disease (347)
Career advice (1700)
Career pathing (33)
CAR-T (239)
CDC (43)
Cell therapy (636)
Cervical cancer (32)
Clinical research (68655)
Collaboration (1399)
Company closure (4)
Compensation (987)
Complete response letters (45)
COVID-19 (2688)
CRISPR (80)
C-suite (639)
Cystic fibrosis (134)
Data (5248)
Decentralized trials (2)
Denatured (24)
Depression (104)
Diabetes (444)
Diagnostics (6578)
Digital health (38)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (202)
Drug pricing (165)
Drug shortages (28)
Duchenne muscular dystrophy (202)
Earnings (89686)
Editorial (49)
Employer branding (21)
Employer resources (151)
Events (116276)
Executive appointments (935)
FDA (18966)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (20)
Funding (1276)
Gene editing (177)
Generative AI (34)
Gene therapy (513)
GLP-1 (903)
Government (4620)
Grass and pollen (6)
Guidances (374)
Healthcare (18858)
HIV (47)
Huntington's disease (38)
IgA nephropathy (74)
Immunology and inflammation (223)
Immuno-oncology (22)
Indications (68)
Infectious disease (2925)
Inflammatory bowel disease (177)
Inflation Reduction Act (13)
Influenza (99)
Intellectual property (200)
Interviews (315)
IPO (16619)
IRA (48)
Job creations (3640)
Job search strategy (1428)
Kidney cancer (15)
Labor market (78)
Layoffs (541)
Leadership (28)
Legal (7941)
Liver cancer (87)
Longevity (12)
Lung cancer (587)
Lymphoma (303)
Machine learning (32)
Management (59)
Manufacturing (633)
MASH (151)
Medical device (13666)
Medtech (13701)
Mergers & acquisitions (19821)
Metabolic disorders (1107)
Multiple sclerosis (139)
NASH (16)
Neurodegenerative disease (250)
Neuropsychiatric disorders (61)
Neuroscience (2636)
NextGen: Class of 2025 (6519)
Non-profit (4498)
Now hiring (59)
Obesity (509)
Opinion (244)
Ovarian cancer (145)
Pain (157)
Pancreatic cancer (182)
Parkinson's disease (241)
Partnered (30)
Patents (426)
Patient recruitment (358)
Peanut (53)
People (58426)
Pharmaceutical (63)
Pharmacy benefit managers (26)
Phase I (21374)
Phase II (30218)
Phase III (22529)
Pipeline (3434)
Policy (257)
Postmarket research (2564)
Preclinical (9125)
Press Release (64)
Prostate cancer (207)
Psychedelics (42)
Radiopharmaceuticals (258)
Rare diseases (645)
Real estate (5945)
Recruiting (69)
Regulatory (23746)
Reports (51)
Research institute (2369)
Resumes & cover letters (351)
Rett syndrome (20)
RNA editing (12)
RSV (72)
Schizophrenia (130)
Series A (203)
Series B (158)
Service/supplier (11)
Sickle cell disease (78)
Special edition (20)
Spinal muscular atrophy (152)
Sponsored (37)
Startups (3603)
State (2)
Stomach cancer (16)
Supply chain (96)
Tariffs (80)
The Weekly (49)
Vaccines (925)
Venture capital (71)
Weight loss (331)
Women's health (68)
Worklife (17)
Date
Today (142)
Last 7 days (301)
Last 30 days (3103)
Last 365 days (30366)
2025 (28371)
2024 (35223)
2023 (40079)
2022 (51174)
2021 (55710)
2020 (54087)
2019 (46542)
2018 (35024)
2017 (32109)
2016 (31481)
2015 (37554)
2014 (31322)
2013 (26345)
2012 (28577)
2011 (29268)
2010 (27331)
Location
Africa (734)
Alabama (74)
Alaska (7)
Arizona (282)
Arkansas (13)
Asia (38834)
Australia (6349)
California (10090)
Canada (3017)
China (919)
Colorado (420)
Connecticut (439)
Delaware (289)
Europe (83759)
Florida (1495)
Georgia (320)
Hawaii (2)
Idaho (61)
Illinois (757)
India (52)
Indiana (475)
Iowa (19)
Japan (342)
Kansas (122)
Kentucky (35)
Louisiana (24)
Maine (70)
Maryland (1288)
Massachusetts (7291)
Michigan (294)
Minnesota (568)
Mississippi (5)
Missouri (117)
Montana (30)
Nebraska (26)
Nevada (109)
New Hampshire (73)
New Jersey (2743)
New Mexico (28)
New York (2698)
North Carolina (1331)
North Dakota (8)
Northern California (4801)
Ohio (297)
Oklahoma (20)
Oregon (37)
Pennsylvania (2088)
Puerto Rico (19)
Rhode Island (44)
South America (1100)
South Carolina (57)
South Dakota (1)
Southern California (3906)
Tennessee (157)
Texas (1544)
United States (36150)
Utah (299)
Vermont (1)
Virginia (235)
Washington D.C. (78)
Washington State (822)
West Virginia (4)
Wisconsin (85)
Wyoming (2)
716,527 Results for "emulate inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emulate Launches Brain-Chip R1 to Advance Neurological Drug Development, in Partnership with FUJIFILM Cellular Dynamics
November 18, 2025
·
6 min read
Press Releases
Emulate Launches AVA™ Emulation System to Accelerate Drug Development With First-of-its-Kind High-Throughput Organ-Chip Platform
June 10, 2025
·
4 min read
BioForest
EMulate Therapeutics Announces the Publication of the Evaluation of Its Ultra-Low Radiofrequency Energy Device in Murine Model of Glioblastoma in BMC Bioelectric Medicine
EMulate Therapeutics, Inc. (EMulate) announces the peer-reviewed publication titled, “Evaluation of the EMulate Therapeutics’ Ultra-Low Radiofrequency Energy (ulRFE®) Device in Murine Model of Glioblastoma (GBM)” in BMC Bioelectronic Medicine.
April 11, 2024
·
5 min read
Press Releases
Emulate Applauds FDA’s Roadmap to Reduce Animal Testing and Embrace Organ-Chip Technologies
April 15, 2025
·
3 min read
BioForest
EMulate Therapeutics Inc. Announces Publication of Clinical Results at the SNO 2023 Conference: GBM and DIPG
EMulate Therapeutics, Inc. (EMTx) proudly announced today the acceptance of their abstract for presentation and publication in the 28th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 2023, in Vancouver, British Columbia.
November 14, 2023
·
5 min read
Drug Development
EMulate Therapeutics Announces the Publication of Its Phase I/II Results in CNS Oncology: “An Expanded Safety/Feasibility Study of the EMulate Therapeutics Voyager™ System in Patients with Recurrent Glioblastoma”
EMulate Therapeutics, Inc. (EMulate) announced today the publication of its peer-reviewed clinical trial using EMulate’s technology for the treatment of glioblastoma in the Journal CNS Oncology https://www.futuremedicine.com/doi/10.2217/cns-2022-0016.
July 18, 2023
·
5 min read
Genetown
Emulate Unveils Chip-A1, Expanding Organ-on-a-Chip Technology Applications Within the Cancer and Cosmetics Markets
Emulate, Inc., the leading provider of next-generation in vitro models, announced the launch of the Emulate Chip-A1™ Accessible Chip through an early access program.
June 26, 2023
·
5 min read
BioForest
EMulate Therapeutics Inc. (EMTx) Announces Company Presentation at Life Sciences Innovation North-West 2023
EMulate Therapeutics announced that Chris Rivera will present an overview of current results and future plans for EMTx at the Life Science Innovation Northwest 2023.
April 18, 2023
·
5 min read
Press Releases
BrYet US, Inc. Expands Patent Portfolio with New U.S. Patent for Targeted Drug Delivery
Near-term applications include combinations with kinase inhibitors (KIs) that achieve enhanced concentration at target sites and synergistic delivery of multiple KIs to the same location
November 13, 2025
·
1 min read
Business
EMulate Therapeutics Announces the Addition of Donna Morgan Murray, Ph.D., to its Board of Directors
EMulate Therapeutics, Inc. today announced the addition of Donna Morgan Murray, Ph.D. to the Company’s board of directors.
March 14, 2023
·
5 min read
1 of 71,653
Next
